Showing 20,861 - 20,880 results of 227,959 for search '(( 5 ((nn decrease) OR (mean decrease)) ) OR ( a ((a decrease) OR (point decrease)) ))', query time: 1.95s Refine Results
  1. 20861

    Analysis of the various EcFicTA complexes in solution. by Frédéric V. Stanger (585551)

    Published 2016
    “…<p>(<i>a</i>) SEC-MALLS analysis of EcFicTA (green), EcFicTA<sub>E28G</sub> (pink), EcFicT<sub>G55R</sub>A (cyan) and EcFicT<sub>G55R</sub>A<sub>E28G</sub> (purple) reveals in each case a 1:1 complex in solution at an eluting concentration of 15 μM. …”
  2. 20862

    S1 Data - by Angélica González Maciel (18946369)

    Published 2024
    “…Mean and SD of zinc in tissues from control and inoculated gerbils with two isolates of Giardia intestinalis: WB and HGINV. A significant decrease was present in zinc levels. …”
  3. 20863
  4. 20864

    Related to Fig 3. by Mohammad Nafees Ansari (22232505)

    Published 2025
    “…(<b>Q</b>) Tumor growth kinetics recorded a significantly higher growth of BT-474_ZFX<sup>OE</sup> (mean ± SEM, <i>n</i> = 5) than BT-474_VECT<sup>OE</sup> tumors. …”
  5. 20865
  6. 20866

    Discovery of a Novel Class of d‑Amino Acid Oxidase Inhibitors Using the Schrödinger Computational Platform by Haifeng Tang (488592)

    Published 2022
    “…d-Serine is a coagonist of the <i>N</i>-methyl d-aspartate (NMDA) receptor, a key excitatory neurotransmitter receptor. …”
  7. 20867
  8. 20868
  9. 20869

    Discovery of a Novel Class of d‑Amino Acid Oxidase Inhibitors Using the Schrödinger Computational Platform by Haifeng Tang (488592)

    Published 2022
    “…d-Serine is a coagonist of the <i>N</i>-methyl d-aspartate (NMDA) receptor, a key excitatory neurotransmitter receptor. …”
  10. 20870
  11. 20871

    Luminal tumors have a deregulated sphingolipid and ganglioside profile and high RICTOR expression. by Mohammad Nafees Ansari (22232505)

    Published 2025
    “…(<b>D</b>–<b>H</b>) Absolute quantification (mean ± SEM, <i>n</i> = 5) of GM3 (D), GD3 (E), GD2 (F), GM2 (G), and GM1 (H) gangliosides in luminal tumor tissues and adjacent normal tissues shows an increase in GM3 and GD3 gangliosides and a decrease in GM1 gangliosides in luminal tumor tissues. …”
  12. 20872

    Feijoa F3 inhibits NF-κB activity in A. MEF cells and B. MEF Atg5<sup>-/-</sup> cells. by Noha Ahmed Nasef (760610)

    Published 2015
    “…A percentage of greater than 100 shows increased inflammatory response in the presence of the ligand when compared to media (no treatment); and a percentage of less than 100 suggests a decrease in the inflammatory response in the presence of the ligand when compared to media (no treatment) meaning that a condition has inhibited NF-κB signaling. …”
  13. 20873
  14. 20874
  15. 20875

    Smoking Is Associated with an Increased Risk of Dementia: A Meta-Analysis of Prospective Cohort Studies with Investigation of Potential Effect Modifiers by Guochao Zhong (701289)

    Published 2015
    “…<div><p>Background</p><p>Previous studies showed inconsistent results on the association of smoking with all-cause dementia and vascular dementia (VaD), and are limited by inclusion of a small number of studies and unexplained heterogeneity. …”
  16. 20876
  17. 20877
  18. 20878
  19. 20879

    Table_5_Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.docx by Xiaofei Wang (135107)

    Published 2022
    “…AZA, MMF, OC and RTX showed a trend to decrease ARR, but those results did not reach significant differences. …”
  20. 20880

    Image_5_Effect of the Rehabilitation Program, ReStOre, on Serum Biomarkers in a Randomized Control Trial of Esophagogastric Cancer Survivors.jpeg by Susan A. Kennedy (9456011)

    Published 2021
    “…Exercise intervention resulted in significant alterations in the level of expression of serum IP-10 (mean difference (MD): 38.02 (95% CI: 0.69 to 75.35)), IL-27 (MD: 249.48 (95% CI: 22.43 to 476.53)), and the vascular injury biomarkers, ICAM-1 (MD: 1.05 (95% CI: 1.07 to 1.66)), and VCAM-1 (MD: 1.51 (95% CI: 1.04 to 2.14)) at T1. A significant increase in eotaxin-3 (MD: 2.59 (95% CI: 0.23 to 4.96)), IL-15 (MD: 0.27 (95% CI: 0 to 0.54)) and decrease in bFGF (MD: 1.62 (95% CI: -2.99 to 0.26)) expression was observed between control and intervention cohorts at T2 (p<0.05).…”